Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)

SHE:301258 Revenue

Suzhou Fushilai Pharmaceutical had revenue of 98.67M CNY in the quarter ending September 30, 2025, with 2.95% growth. This brings the company's revenue in the last twelve months to 439.57M, up 6.39% year-over-year. In the year 2024, Suzhou Fushilai Pharmaceutical had annual revenue of 429.47M, down -12.23%.

• Revenue (ttm): 439.57M
• Revenue Growth: +6.39%
• P/S Ratio: 7.57
• Revenue / Employee: 838.87K
• Employees: 524
• Market Cap: 3.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	429.47M	-59.82M	-12.23%
Dec 31, 2023	489.29M	-78.92M	-13.89%
Jan 1, 2023	568.21M	46.52M	8.92%
Jan 1, 2022	521.70M	44.85M	9.40%
Dec 31, 2020	476.85M	24.35M	5.38%